Clonal Dominance of Hematopoietic Stem Cells Triggered by Retroviral Gene Marking

Author:

Kustikova Olga12345,Fehse Boris12345,Modlich Ute12345,Yang Min12345,Düllmann Jochen12345,Kamino Kenji12345,von Neuhoff Nils12345,Schlegelberger Brigitte12345,Li Zhixiong12345,Baum Christopher12345

Affiliation:

1. Bone Marrow Transplantation, University Hospital Eppendorf, Martinistraße 52, 20251 Hamburg, Germany.

2. Institute for Anatomy II: Experimental Morphology, University Hospital Eppendorf, Martinistraße 52, 20251 Hamburg, Germany.

3. Department of Hematology, Hemostaseology, and Oncology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany.

4. Institute of Cellular and Molecular Pathology, Hannover Medical School, Carl-Neuberg-Straße 1, 30625 Hannover, Germany.

5. Division of Experimental Hematology, Cincinnati Children's Hospital Medical Center, Cincinnati, OH 45229–3039, USA.

Abstract

Gene marking with replication-defective retroviral vectors has been used for more than 20 years to track the in vivo fate of cell clones. We demonstrate that retroviral integrations themselves may trigger nonmalignant clonal expansion in murine long-term hematopoiesis. All 29 insertions recovered from clones dominating in serially transplanted recipients affected loci with an established or potential role in the self-renewal or survival of hematopoietic stem cells. Transcriptional dysregulation occurred in all 12 insertion sites analyzed. These findings have major implications for diagnostic gene marking and the discovery of genes regulating stem cell turnover.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Cited by 293 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

1. CAR-T and CAR-NK as cellular cancer immunotherapy for solid tumors;Cellular & Molecular Immunology;2024-08-12

2. Retrovirale Vektoren – Effiziente Gentaxis für unterschiedliche Gentherapien;Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft;2023-12-30

3. Gentherapie aus der Sicht eines forschenden Arzneimittelunternehmens;Gen- und Zelltherapie 2.023 - Forschung, klinische Anwendung und Gesellschaft;2023-12-30

4. EVI1-mediated Programming of Normal and Malignant Hematopoiesis;HemaSphere;2023-10

5. AAV-mediated delivery of a Sleeping Beauty transposon and an mRNA-encoded transposase for the engineering of therapeutic immune cells;Nature Biomedical Engineering;2023-07-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3